Prospective care of heart failure in Japan: Lessons from CHART studies

EPMA Journal

Volumn 2, Issue 4, 2011, Pages 425-438

  Shiba, Nobuyuki ^a   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular risks; Coronary artery disease; Elderly; Personalized medicine; Prevention; Undertreatment

Indexed keywords

AGING; BIRTH RATE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DYSLIPIDEMIA; ETHNIC DIFFERENCE; GERIATRIC ASSESSMENT; HEALTH BEHAVIOR; HEART FAILURE; HUMAN; HYPERTENSION; JAPAN; LIFESTYLE; MORTALITY; PATIENT CARE; PERSONALIZED MEDICINE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEX DIFFERENCE;

EID: 84855294379     PISSN: 18785077     EISSN: 18785085     Source Type: Journal    
DOI: 10.1007/s13167-011-0097-7     Document Type: Review

References (70)

1. Chronic diseases, World Health Organization. URLhttp://www. who. int/topics/chronic_diseases/en/.
2. Golubnitschaja O, editor. Predictive diagnostics and personalized treatment: dream or reality? NewYork: Nova Science Publishers Inc; 2009.
3. Dupree CS. Primary prevention of heart failure: an update. Curr Opin Cardiol. 2010; 25: 478-83.
4. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics 2011 update: a report from the American Heart Association. Circulation. 2011; 123: e18-e209.
5. Mendez GF, Cowie MR. The epidemiological features of heart failure in developing countries: a review of the literature. Int J Cardiol. 2001; 80: 213-9.
6. Ueshima H. Explanation for the Japanese paradox: prevention of increase in coronary heart disease and reduction in stroke. J Atheroscler Thromb. 2007; 14: 278-86.
7. Vital statics in Japan. Vital and Health Statistics Division, Statistics and Information Department, Minister's Secretariat, Ministry of Health, Labour and Welfare. URL http://www. e-stat. go. jp/SG1/estat.
8. Shiba N, Watanabe J, Shinozaki T, Koseki Y, Sakuma M, Kagaya Y, et al. Analysis of chronic heart failure registry in the Tohoku district: third year follow-up. Circ J. 2004; 68: 427-34.
9. Shiba N, Shimokawa H. Chronic heart failure in Japan: implications of the CHART studies. Vasc Health Risk Manag. 2008; 4: 103-13.
10. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation / American Heart Association task force on practice guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 2009; 53: e1-e90.
11. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur Heart J. 2008; 29: 2388-442.
12. Arnold JM, Howlett JG, Dorian P, Ducharme A, Giannetti N, Haddad H, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure update 2007: prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Can J Cardiol. 2007; 23: 21-45.
13. Heart Failure Society of America. Executive summary: HFSA 2006 comprehensive heart failure practice guideline. J Card Fail. 2006; 12: 10-38.
14. Shiba N, Nochioka K, Miura M, Kohno H, Kohno H, CHART-2 Investigators. Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan. Circ J. 2011; 75: 823-33.
15. National Institute of Population and Social Security Research. (in Japanese) URL http://www. ipss. go. jp/syoushika/tohkei/Popular/Popular2011. asp?chap=0.
16. Erlinger TP, Appel LJ. Dietary patterns and coronary heart disease. In: Marmot M, Elliott P, editors. Coronary heart disease epidemiology: from aetiology to public health. 2nd ed. Oxford: Oxford University Press; 2005. p. 207-19.
17. Egusa G, Yamane K. Lifestyle, serum lipids and coronary artery disease: comparison of Japan with the United States. J Atheroscler Thromb. 2004; 11: 304-12.
18. The National Nutrition Survey of Japan. (in Japanese) URL http://www. mhlw. go. jp/bunya/kenkou/kenkou_eiyou_chousa. html.
19. Ueshima H. Changes in dietary hibits, cardiovascular risk factors and mortality in Japan. Acta Cardiol. 1990; 45: 311-27.
20. Morris JN, Haskell WL. Exercise versus heart attack: history of a hypothesis. Addendum to chapter 19. In: Marmot M, Elliott P, editors. Coronary heart disease epidemiology: From aetiology to public health. 2nd ed. Oxford: Oxford University Press; 2005. p. 275-90.
21. Shibata Y, Hayasaka S, Yamada T, Goto Y, Ojima T, Ishikawa S, et al. Physical activity and cardiovascular disease in Japan: the Jichi Medical School Cohort Study. J Epidemiol. 2010; 20: 225-30.
22. He FJ, MacGregor GA. A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens. 2009; 23: 363-84.
23. Martiniuk AL, Lee CM, Lawes CM, Ueshima H, Suh I, Lam TH, et al. Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region. J Hypertens. 2007; 25: 73-9.
24. Lawes CM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, et al. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003; 21: 707-16.
25. Woodward M, Zhang X, Barzi F, Pan W, Ueshima H, Rodgers A, et al. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care. 2003; 26: 360-6.
26. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27: 1047-53.
27. National Survey on Diabetes Mellitus Prevalence in Japan. (in Japanese) URL http://www. mhlw. go. jp/houdou/2008/12/dl/h1225-5d. pdf and http://www. mhlw. go. jp/shingi/2004/03/s0318-15. html(access on March 9, 2011).
28. Ueshima H, Sekikawa A, Miura K, Turin TC, Takashima N, Kita Y, et al. Cardiovascular disease and risk factors in Asia: a selected review. Circulation. 2008; 118: 2702-9.
29. Ueshima H, Tatara K, Asakura S, Okamoto M. Declining trends in blood pressure level and the prevalence of hypertension, and changes in related factors in Japan. 1956-1980. J Chron Dis. 1987; 40: 137-47.
30. Nakamura K, Okamura T, Hayakawa T, Hozawa A, Kadowaki T, Murakami Y, et al. The proportion of individuals with obesity-induced hypertension among total hypertensives in a general Japanese population: NIPPON DATA 80, 90. Eur J Epidemiol. 2007; 22: 691-8.
31. Shiraishi J, Kohno Y, Sawada T, Nishizawa S, Arihara M, Hadase M, et al. Relation of obesity to acute myocardial infarction in Japanese patients. Differences in gender and age. Circ J. 2006; 70: 1525-30.
32. Woodward M, Lam TH, Barzi F, Patel A, Gu D, Rodgers A, et al. Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Int J Epidemiol. 2005; 34: 1036-45.
33. Martiniuk AL, Lee CM, Lam TH, Huxley R, Suh I, Jamrozik K, et al. The fraction of ischaemic heart disease and stroke attributable to smoking in the WHO Western Pacific and South-East Asian region. Tabacco. Control. 2006; 15: 181-8.
34. Ueshima H. Trends in Asia. In: Marmot M, Elliott P, editors. Coronary heart disease epidemiology: from aetiology to public health. 2nd ed. Oxford: Oxford University Press; 2005. p. 102-11.
35. Noda H, Iso H, Irie F, Sairenchi T, Ohtaka E, Ohta H. Gender difference of association between LDL cholesterol concentrations and mortality from coronary heart disease amongst Japanese: the Ibaraki Prefectural Health Study. J Intern Med. 2010; 267: 576-87.
36. Arai H, Yamamoto A, Matsuzawa Y, Saito Y, Yamada N, Oikawa S, et al. Serum lipid survey and its recent trend in the general Japanese population in 2000. J Atheroscler Thromb. 2005; 12: 98-106.
37. Ueshima H, Iida M, Shimamoto T, Konishi M, Tanigaki M, Doi M, et al. Dietary intake and serum total cholesterol level: their relationship to different lifestyle in several Japanese populations. Circulation. 1982; 66: 519-26.
38. Nakamura Y, Hozawa A, Turin TC, Takashima N, Okamura T, Hayakawa T, et al. NIPPON DATA80 Research Group. Dietary habits in middle age and future changes in activities of daily living-NIPPON DATA80. Gerontology. 2009; 55: 707-13.
39. Roger VL, Jacobsen SJ, Weston SA, Bailey KR, Kottke TE, Frye RL. Trends in heart disease deaths in Olmsted County, Minnesota, 1979-1994. Mayo Clin Proc. 1999; 74: 651-7.
40. McGovern PG, Jacobs Jr DR, Shahar E, Arnett DK, Folsom AR, Blackburn H, et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: the Minnesota heart survey. Circulation. 2001; 104: 19-24.
41. Kodama K, Sasaki H, Shimizu Y. Trend of coronary heart disease and its relationship to risk factors in a Japanese population: a 26-year follow-up, Hiroshima/Nagasaki Study. Jap Circ J. 1990; 54: 414-21.
42. Kitamura A, Sato S, Kiyama M, Imano H, Iso H, Okada T, et al. Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan, 1964 to 2003. The Akita-Osaka Study. J Am Coll Cardiol. 2008; 52: 71-9.
43. Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K, et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama Study. Stroke. 2003; 34: 2349-54.
44. van der Bom JG, Grobbee DE. Risk factors in the elderly. In: Marmot M, Elliott P, editors. Coronary heart disease epidemiology: from aetiology to public health. 2nd ed. Oxford: Oxford University Press; 2005. p. 606-26.
45. A report from the Tokyo Fire Department on January 5, 2011. (in Japanese) URL http://www. tfd. metro. tokyo. jp/hp-kouhouka/pdf/230105. pdf.
46. Miettinen TA, Pyörälä K, Olsson AG, Musliner TA, Cook TJ, Faergeman O, et al. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction of angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S). Circulation. 1997; 96: 4211-8.
47. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998; 279: 1615-22.
48. Kannel WB, Gordan T. Evaluation of cardiovascular risk in the elderly: the Framingham study. Bull N Y Acad Med. 1978; 54: 573-91.
49. MacMahon S, Rodgers A. The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hypertens. 1993; 15: 967-78.
50. Mulrow CD, Cornell JA, Herrera CR, Kadri A, Farnett L, Aguilar C. Hypertension in the elderly: implications and generalizability of randomized trials. JAMA. 1994; 272: 1932-8.
51. Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008; 358: 1887-98.
52. Houterman S, Boshuizen HC, Verschuren WM, Giampaoli S, Nissinen A, Menotti A, et al. Predicting cardiovascular risk in the elderly in different European countries. Eur Heart J. 2002; 23: 294-300.
53. Hermanson B, Hermanson GS, Kronmal RA, Gersh BJ. Beneficial sex-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. N Engl J Med. 1988; 319: 1365-9.
54. Psaty BM, Furberg CD, Kuller LH, Bild DE, Rautaharju PM, Polak JF, et al. Traditional risk factors and subc1inical disease measures as predictors of first myocardial infarction in older adults: the Cardiovascular Health Study. Arch Intern Med. 1999; 159: 1339-47.
55. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes. 1994; 43: 960-7.
56. Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, et al. Fasting glucose concentration, diabetes mellitus, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010; 375: 2215-22.
57. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, et al. Prevalence of hypertension in the US adult population: results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995; 25: 305-13.
58. Shiba N, Nochioka K, Kohno H, Matsuki M, Takahashi J, Tada T, et al. Emerging problems of heart failure practice in Japanese women: lessons from the CHART study. Circ J. 2008; 72: 2009-14.
59. Shiba N, Shimokawa H. Chronic kidney disease and heart failure-Bidirectional close link and common therapeutic goal. J Cardiol. 2011; 57: 8-17.
60. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006; 113: 671-8.
61. Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006; 27: 397-412.
62. Mazza A, Zamboni S, Rubello D, Schiavon L, Zorzan S, Casiglia E. Chronic obstructive pulmonary disease and cardiovascular mortality in elderly subjects from general population. Blood Pressure. 2010; 19: 67-74.
63. Kjøller E, Køber L, Iversen K, Torp-Pedersen C, Trace Study Group. Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction. Eur J Heart Fail. 2004; 6: 71-7.
64. Asanuma H, Kitakaze M. The largest cohort study opens a new era for the management of heart failure in Japan. Circ J. 2011; 75: 775-76.
65. Ho KK, Anderson KM, Kannel WB, Grossman W, Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study. Circulation. 1993; 88: 107-15.
66. Adams Jr KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100, 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005; 149: 209-16.
67. Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J. 2006; 27: 2725-36.
68. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006; 355: 251-9.
69. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006; 355: 260-9.
70. Shiba N, Watanabe J, Shinozaki T, Koseki Y, Sakuma M, Kagaya Y, et al. Poor prognosis of Japanese patients with chronic heart failure following myocardial infarction-comparison with nonischemic cardiomyopathy. Circ J. 2005; 69: 143-9.